atovaquone and Infection, Toxoplasma gondii
atovaquone has been researched along with Infection, Toxoplasma gondii in 21 studies
Research
Studies (21)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Araujo, FG; Chan, JM; Ling, Y; Moreno, SN; Odeh, S; Oldfield, E; Sahota, G | 1 |
| Alday, PH; Doggett, JS; Nilsen, A | 1 |
| Rodriguez, JB; Szajnman, SH | 1 |
| Anderson, AD; Camargo, JF; Chueng, TA; Komanduri, KV; Moroz, IV; Morris, MI | 1 |
| Amani, A; Azami, SJ; Faramarzi, MA; Keshavarz, H; Mahmoudi, M; Mohebali, M; Najafi-Taher, R; Shojaee, S | 1 |
| Daryani, A; Mehrzadi, S; Montazeri, M; Sarvi, S; Shahdin, S; Sharif, M | 1 |
| Ayuk, F; Bacher, A; Bacher, U; Christopeit, M; Klyuchnikov, E; Kröger, N; Langebrake, C; Mendorf, A; Regier, M; Rohde, H; Stübig, T; Wolschke, C; Zabelina, T | 1 |
| Ananthanarayanan, V; Fedson, S; Husain, AN; Kim, G; Murks, C; Petty, LA; Potter, L; Pursell, K; Qamar, S | 1 |
| Davis, LA; Davis, PH; Judge, AK; Larson, JJ; Neville, AJ; Vennerstrom, JL; Wang, X; Zach, SJ | 1 |
| Ansari, M; Garcia de la Fuente, I; Gumy-Pause, F; Lobrinus, JA; Ozsahin, H; Passweg, JR; Posfay-Barbe, KM; Rougemont, AL | 1 |
| Campistol, JM; Cervera, C; Cofan, F; Esforzado, N; Hoyo, I; Linares, L; Martina, MN; Miro, JM; Moreno, A; Oppenheimer, F; Sanclemente, G; Torregrosa, V | 1 |
| Ioannidis, J; Wilkinson, D | 2 |
| Aleksić, A; Bobić, B; Djurković-Djaković, O; Klun, I; Nikolić, A | 1 |
| Kessl, JJ; Meshnick, SR; Trumpower, BL | 1 |
| Goa, KL; Spencer, CM | 1 |
| Bryan, E; McFarland, J; Sackoff, J; Su, S | 1 |
| Walker, MJ | 1 |
| Cadman, J; Torres, G | 1 |
| Araujo, FG; Huskinson, J; Remington, JS | 1 |
Reviews
8 review(s) available for atovaquone and Infection, Toxoplasma gondii
| Article | Year |
|---|---|
An updated review of chemical compounds with anti-Toxoplasma gondii activity.
Topics: Animals; Atovaquone; Female; Humans; Mammals; Pregnancy; Toxoplasma; Toxoplasmosis; Trimethoprim | 2023 |
Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review.
Topics: Abietanes; Animals; Antiparasitic Agents; Atovaquone; Azithromycin; Brain; Cysts; Humans; Hydroxyzine; Mice; Peptides, Cyclic; Toxoplasma; Toxoplasmosis; Toxoplasmosis, Animal | 2018 |
Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antiprotozoal Agents; Antipsychotic Agents; Atovaquone; Clindamycin; Drug Repositioning; Humans; Macrolides; Parasitic Sensitivity Tests; Pyrimethamine; Sulfadiazine; Toxoplasma; Toxoplasmosis | 2015 |
Toxoplasma gondii primary infection in renal transplant recipients. Two case reports and literature review.
Topics: Adolescent; Adult; Antibodies, Protozoan; Atovaquone; Female; Humans; Immunoglobulin M; Kidney Transplantation; Male; Middle Aged; Tissue Donors; Toxoplasma; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
HIV: opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Antitubercular Agents; Antiviral Agents; Atovaquone; Azithromycin; Chickenpox; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Ganciclovir; Herpes Simplex; Humans; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Pneumonia, Pneumocystis; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary; Valacyclovir; Valine | 2003 |
HIV: prevention of opportunistic infections.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Antiviral Agents; Atovaquone; Azithromycin; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Famciclovir; Herpes Simplex; Herpes Zoster; Humans; Mycobacterium avium-intracellulare Infection; Mycoses; Naphthoquinones; Pneumonia, Pneumocystis; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary; Valacyclovir; Valine | 2003 |
Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi.
Topics: Amino Acid Sequence; Animals; Anti-Infective Agents; Atovaquone; Electron Transport Complex III; Enzyme Inhibitors; Humans; Malaria, Falciparum; Models, Molecular; Molecular Sequence Data; Plasmodium falciparum; Pneumocystis carinii; Pneumonia, Pneumocystis; Sequence Alignment; Toxoplasma; Toxoplasmosis; Yeasts | 2007 |
Atovaquone. A review of its pharmacological properties and therapeutic efficacy in opportunistic infections.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiprotozoal Agents; Atovaquone; Clinical Trials as Topic; Drug Evaluation; Drug Interactions; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Toxoplasmosis | 1995 |
Trials
1 trial(s) available for atovaquone and Infection, Toxoplasma gondii
| Article | Year |
|---|---|
Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Dapsone; Ethnicity; Female; HIV Infections; Humans; Longitudinal Studies; Male; Medical Records; Mycobacterium avium-intracellulare Infection; Naphthoquinones; New York City; Pentamidine; Pneumonia, Pneumocystis; Practice Guidelines as Topic; Regression Analysis; Rifabutin; Risk-Taking; Time Factors; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; United States; United States Public Health Service | 1998 |
Other Studies
12 other study(ies) available for atovaquone and Infection, Toxoplasma gondii
| Article | Year |
|---|---|
Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations.
Topics: Aldose-Ketose Isomerases; Alkyl and Aryl Transferases; Animals; Antiprotozoal Agents; Cell Line; Diphosphonates; Fosfomycin; Geranyltranstransferase; Humans; Mice; Models, Molecular; Multienzyme Complexes; Oxidoreductases; Quantitative Structure-Activity Relationship; Toxoplasma; Toxoplasmosis | 2005 |
Structure-activity relationships of
Topics: Animals; Antiprotozoal Agents; Atovaquone; Cytochromes; Humans; Structure-Activity Relationship; Toxoplasma; Toxoplasmosis | 2022 |
Failure of atovaquone prophylaxis for prevention of toxoplasmosis in hematopoietic cell transplant recipients.
Topics: Atovaquone; Hematopoietic Stem Cell Transplantation; Humans; Toxoplasmosis; Transplant Recipients; Treatment Failure | 2020 |
Nanoemulsion of atovaquone as a promising approach for treatment of acute and chronic toxoplasmosis.
Topics: Acute Disease; Animals; Anti-Infective Agents; Atovaquone; Chronic Disease; Emulsions; Female; Grape Seed Extract; HeLa Cells; Humans; Mice, Inbred BALB C; Nanostructures; Toxoplasma; Toxoplasmosis | 2018 |
Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Atovaquone; Brain Diseases; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; Toxoplasmosis; Transplantation, Homologous; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2015 |
Cardiac toxoplasmosis after heart transplantation diagnosed by endomyocardial biopsy.
Topics: Adult; Anti-Infective Agents; Atovaquone; Biopsy; Heart Transplantation; Humans; Male; Myocardium; Postoperative Complications; Toxoplasmosis | 2015 |
Acute disseminated fatal toxoplasmosis after haploidentical stem cell transplantation despite atovaquone prophylaxis in a young man.
Topics: Acute Disease; Anti-Infective Agents; Antibiotic Prophylaxis; Atovaquone; Fatal Outcome; Haploidy; Hematopoietic Stem Cell Transplantation; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reverse Transcriptase Polymerase Chain Reaction; Toxoplasmosis; Treatment Failure; Young Adult | 2010 |
Stage conversion of Toxoplasma gondii RH parasites in mice by treatment with atovaquone and pyrrolidine dithiocarbamate.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Brain; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Female; Mice; Naphthoquinones; Oocysts; Pyrrolidines; Thiocarbamates; Toxoplasma; Toxoplasmosis | 2005 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Opportunistic infections studies update.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antitubercular Agents; Atovaquone; Candidiasis; Clinical Trials as Topic; Cryptosporidiosis; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Immunotherapy; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Paromomycin; Pneumonia, Pneumocystis; Pyrimethamine; Toxoplasmosis; Tuberculosis | 1995 |
Optimizing PCP therapy.
Topics: Aerosols; AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; CD4 Lymphocyte Count; Clinical Trials as Topic; Dapsone; Drug Administration Schedule; Encephalitis; Humans; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-Infective Agents; Atovaquone; Brain; Cell Division; Female; Humans; Mice; Mice, Inbred CBA; Naphthoquinones; Toxoplasma; Toxoplasmosis; Uracil | 1991 |